Navigation Links
Depression And Diabetes Are Mutually Exclusive.

It is a common assumption that the elderly patients who are depressed and diabetic may not respond well to clinical intervention programs, till such time they come out of their depression. // This hypothesis actually leads them to being excluded from such intervention modules. Infact, Researchers have confirmed that there is no strong connection between depression in elderly patients with diabetes and the extent to which they discipline their blood sugar levels.

A study was conducted by the researchers at Suny Upstate University, Syracuse, New York, where about 1600 elderly diabetic, participated in a diabetes care management program.

During the initial phase of the study, it was observed that there was a marked relationship between depression and diabetes control. The significant pointer was that depression did not cause an alteration in blood sugar control in patients, irrespective of whether they were part of an intervention program or underwent the usual treatment.

Researchers were able to rest the issue confirming that depression should not be used as a reason to exclude patients from clinical intervention programs, because it is fairly disconnected with diabetes.


'"/>




Page: 1

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Depression may cause delayed wound healing
3. Diabetes and Depression often go hand-in-hand
4. Depression and heart failure
5. Depression disturbs heart rate
6. Depression a possible danger in elderly
7. Depression linked to mortality
8. Depression increases heart attacks
9. More People Seeking Treatment for Depression
10. Depression elevates heart failure risk
11. Depression hurts the heart
Post Your Comments:
(Date:7/25/2008)... Authority offers patients consumers tips and enco...nt safety, HARRISBURG, Pa., July 25 /PRNewswire-U...ority today supports "National Patient Safety Day"...and their families to,participate fully in their h...ing they can about their surgery or illness., "We...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)...ck to benefit ALS Therapy Alliance to be presented...ight, WOONSOCKET, R.I., July 25 /PRNewswire/ -- C...raised a record-breaking $4.4 million in just 21 d...gn for ALS research. This is,the seventh year of t...aised more than $15 million for ALS research. This...
(Date:7/25/2008)... The Retina Group of New York wi...lated macular degeneration especially designed for...ale Public Library at 116 Merritts Road, Farmingda...15. Attendance is free and refreshments will be pr...516) 939-6100. , Hicksvil...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...ined that the deadly Human Immune Deficiency Virus...accine used in Africa in the 1950s and say rumours...ce to back them up. The studies, from researchers ...d help free the polio vaccine manufactured by the ...
... most painful and bothering one is the trauma of g... according to many diabetics is the finger stick. ...p to six times a day for more than ten to twenty y...he pain and discomfort associated with them. But r...
...hursday that plans are afoot to consider listing o...n the US bourses after 2002," Pratap C Reddy, chai... was a part of the business plan for the post-2002...available at the moment, Dr. Reddy added that plan...
... can be prevented if the patients and their doctor...ng to WHO, around 150 million people suffer from a...o the disease every year. Asthma is a chronic resp...t is characterized by sudden recurring attacks of ...
Other Medicine News:
(Date:7/24/2008)...-FirstCall/ -- Alexza,Pharmaceuticals, Inc. (Nasda...ts second Phase 3 clinical trial with AZ-004 (Stac... candidate being developed for the treatment,of ac...polar disorder.,Alexza believes the novel, non-inv...ties resulting from inhaled loxapine administratio...
(Date:7/24/2008).../ -- Headlines claiming "soy,products lower sperm ...e,preliminary study that Dr. Jorge Chavarro, publ...collected intake of soyfoods and not on,specific d...d by many,issues, thus I feel the results should b... Tammy Hedlund, a researcher in prostate cancer,pr...
(Date:7/24/2008)... body temperature, for home,and clinical use, WES...-Med, Inc.,(subsidiary of American Scientific Reso...ibutor of the Thermofocus(R) 5-in-1 non-contact,th... clinical study,conducted by the Second Children,s...y, which proves that the Thermofocus(R) measures b...
(Date:7/24/2008)...ire-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX)...week,open label safety extension that was conducte...y for naproxcinod. The results revealed no unexpec...r the one-year duration of,the study, as measured ...ion, the results showed that the patients, mean bl...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Armed beetles find a mate whatever their size 2646 1Small Business Health Care Survey Points to Need for Reform 15325 1Small Business Health Care Survey Points to Need for Reform 15325 2Clarient to Present at the B Riley 26 Co 9th Annual Las Vegas Investor Conference 15320 1Clarient to Present at the B Riley 26 Co 9th Annual Las Vegas Investor Conference 15320 2Patient Experience Expert to Present The Power of Wow 21 in Health Care Service Delivery 4227 1Patient Experience Expert to Present The Power of Wow 21 in Health Care Service Delivery 4227 2
...PRNewswire/ -- Asenapine -- an,investigational dru... business unit of Akzo Nobel, for bipolar I disord...e effective than placebo,in treating acute manic a...er, according to new Phase III results, from a stu...on,s 2007 Annual,Meeting. , In the three-week stud...
...ent Reduction in Risk of Hospitalization,from Croh...Ill., May 22, 2007 /PRNewswire-FirstCall/ -- Abbot... of a pivotal study,presented at the Digestive Dis...ng patients with moderate to severely active,Crohn...ntenance,therapy were almost 60 percent less likel...
Other Medicine Technology:Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: